Process for the crystallization of (R)- or (S)-lansoprazole

Details Process for the crystallization of (R)- or (S)-lansoprazole Process for the crystallization of (R)- or (S)-lansoprazole

2007-10-23

2007-10-23

Morris, Patricia L. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

10432798

ABSTRACT:
The present invention relates to a production method of a crystal of (R)-lansoprazole or (S)-lansoprazole, which includes crystallization at a temperature of about 0° C. to about 35° C. from a C1-4alkyl acetate solution containing (R)-lansoprazole or (S)-lansoprazole at a concentration of about 0.1 g/mL to about 0.5 g/mL and the like. According to the production method of the present invention, a crystal of (R)-lansoprazole or (S)-lansoprazole superior in preservation stability can be produced efficiently on an industrial large scale.

REFERENCES:
patent: 6002011 (1999-12-01), Kato et al.
patent: 6462058 (2002-10-01), Fujishima et al.
patent: 6608092 (2003-08-01), Fujishima et al.
patent: 6664276 (2003-12-01), Fujishima et al.
patent: 0174726 (1986-03-01), None
patent: 0302720 (1989-02-01), None
patent: 1277752 (2003-01-01), None
patent: 1293507 (2003-03-01), None
patent: WO96/02535 (1996-02-01), None
patent: WO97/02261 (1997-01-01), None
patent: WO98/21201 (1998-05-01), None
patent: 9938512 (1999-05-01), None
patent: WO 00/78745 (2000-12-01), None
patent: WO 01/14366 (2001-03-01), None
Kotar et al. (Eur. J of Pharm Sci., 4 (1996), p. S182.
Brittain, H.G., Polymorphism in Pharmaceutical Soldis-Drugs and the Pharmaceutical Sciences, 95, 1999, pp. 126-358.
Chemical & Engineering News, Feb. 2003, pp. 32-35.
Halbein et al., Journal of Pharmaceutical Sciences, 58 (1969) pp. 911-928.
US Pharmacopia, 1995, pp. 1843-1844.
Concise Encyclopedia Chemistry, pp. 872-873 (1993).
Muzaffar et al., “Polymorphism and Drug, etc.,” J of Pharmacy (Lahore), 1979, 1(1), 59-66.
Jain et al., “Polymorphism in Pharmacy”, Indian Drugs, 1986, 23(6), 315-329.
Doelker et al., CA 132:325872 (1999).
Taday et al., “Using Terahertz, etc.,” J of Pharm. Sci., 92(4), 2003, 831-838.
Otsuka et al., “Effect of Polymorphic, etc.,” Chem. Pharm. Bull. 47(6) 852-856 (1999).
Ulicky et al., Comphrehensive Dictionary, etc., NY: Prentice Hall, 1992, 21.
Brittain et al., “Polymorphism in Pharmaceutical Solids”, NY: Marcel Dekker et al., (1999), pp. 1-2, 125-181, 183-226, 228-278.

Affiliated with

Also associated with

Rating

Process for the crystallization of (R)- or (S)-lansoprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the crystallization of (R)- or (S)-lansoprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the crystallization of (R)- or (S)-lansoprazole will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3844122